Suchergebnisse - "Pro, Barbara"

PubPharm (252)

1

A phase 1-2 trial of DA-EPOCH-R plus ixazomib for MYC-aberrant lymphoid malignancies : the DACIPHOR regimen

enthalten in: Blood advances | 2024

von Karmali, R. | Galvez, C. | Hamadani, M. | +14

2

Impact of Race and Social Determinants of Health on Outcomes in Patients with Aggressive B-cell nHL Treated with CAR-T

enthalten in: Blood advances | 2024

von Karmali, R. | Machhi, R. | Epperla, N. | +28

3

Phase II study of the novel antifolate agent pralatrexate in combination with the histone deacetylase inhibitor romidepsin for the treatment of patients with mature T-cell lymphoma

enthalten in: Leukemia & lymphoma | 2024

von Ryu Tiger, Y. | Jain, S. | Barta, S. | +7

4

Identifying and addressing unmet clinical needs in primary cutaneous B-cell lymphoma : A consensus-based paper from an ad-hoc international panel

enthalten in: Hematological oncology | 2024

von Quaglino, P. | Pimpinelli, N. | Zinzani, P. | +14

5

Hypereosinophilic syndrome with leptomeningeal involvement : a not-so-classical case report of classical Hodgkin Lymphoma

enthalten in: Leukemia & lymphoma | 2023

von Mellgard, G. | Stoffel, E. | Michel, A. | +5

6

Integrative analysis of clinicopathological features defines novel prognostic models for mantle cell lymphoma in the immunochemotherapy era : a report from The North American Mantle Cell Lymphoma Consortium

enthalten in: Journal of hematology & oncology | 2023

von Vose, J. | Fu, K. | Wang, L. | +42

7

Integrative analysis of clinicopathological features defines novel prognostic models for mantle cell lymphoma in the immunochemotherapy era: a report from The North American Mantle Cell Lymphoma Consortium

enthalten in: Journal of hematology & oncology | 2023

von Vose, J. | Fu, K. | Wang, L. | +41

8

Ibrutinib maintenance after frontline treatment in patients with mantle cell lymphoma

enthalten in: Blood advances | 2023

von Karmali, R. | Abramson, J. | Stephens, D. | +12

CommentIn: Blood Adv. 2023 Dec 12;7(23):7358-7360. - PMID 38085554

9

How I treat posttransplant lymphoproliferative disorder

enthalten in: Blood | 2023

von Amengual, J. | Pro, B.

10

Multicenter phase 2 study of romidepsin plus lenalidomide for previously untreated peripheral T-cell lymphoma

enthalten in: Blood advances | 2023

von Ruan, J. | Zain, J. | Palmer, B. | +9

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[26]